Circular No. 01/2026/TT-BYT on the List of Centralized Procurement at the National Level for Medical Equipment and Laboratory Supplies

Circular No. 01/2026/TT-BYT promulgates the list of centralized procurement at the national level for medical equipment and laboratory supplies to enhance the efficiency of resource utilization in the healthcare sector. This document specifies the types of equipment and supplies that need to be centrally procured and the principles for compiling the list.

Document No.01/2026/TT-BYT
Document typeCircular
Issuing authorityMinistry of Health
Signed byĐỗ Xuân Tuyên — Thứ trưởng
Updated12/06/2026
Issued date09/01/2026
Effective date01/03/2026
Expiry date
StatusIn effect
✦ Smart summary

Circular No. 01/2026/TT-BYT promulgates the list of centralized procurement at the national level for medical equipment and laboratory supplies to enhance the efficiency of resource utilization in the healthcare sector. This document specifies the types of equipment and supplies that need to be centrally procured and the principles for compiling the list.

Scope of application

Agencies, organizations, and units related to the procurement of medical equipment and laboratory supplies in the healthcare sector

Key points

  • Medical equipment and laboratory supplies included in the list must meet criteria regarding high cost, frequent use, and impact on the payment capacity of the Health Insurance Fund (Article 2).
  • The list includes artificial intraocular lenses with specific characteristics concerning material, color, and size (Article 3.1).
  • Types of coronary artery stent supports are included in the list based on coating and stent frame thickness criteria (Article 3.2).
  • This Circular takes effect from March 1, 2026, but centralized procurement will only commence from January 1, 2027 (Articles 4 and 5).
  • The Medical Infrastructure and Equipment Department is responsible for compiling and reporting to the Ministry of Health to amend the list in accordance with practical circumstances (Article 6.1).

🌐 Social impact of this document

  • Enhance the efficiency of resource utilization in the healthcare sector through centralized procurement.
  • Reduce costs for the Health Insurance Fund due to bulk purchasing of similar types.
  • Healthcare facilities may face initial difficulties adapting to the new procedures.
  • Patients and the public will benefit from reduced prices of medical equipment and laboratory supplies.

❓ Frequently asked questions

What types of equipment and supplies are included in the centralized procurement list?

The list includes artificial intraocular lenses and coronary artery stent supports with specific characteristics concerning material, color, and size.

When does this Circular take effect?

This Circular takes effect from March 1, 2026, but centralized procurement will only commence from January 1, 2027.

What are the criteria for including medical equipment and laboratory supplies in the list?

Medical equipment and laboratory supplies must meet criteria regarding high cost, frequent use, and professional requirements.

Who is responsible for compiling and reporting to the Ministry of Health to amend the list?

The Medical Infrastructure and Equipment Department has this responsibility (Article 6.1).

When does centralized procurement begin?

Centralized procurement begins from January 1, 2027.

Full text

MINISTRY OF HEALTH SOCIALIST REPUBLIC OF VIET NAM
Independence - Freedom - Happiness
Number: 01/2026/TT-BYT Hanoi, January 9, 2026

CIRCULAR

Issuing the centralized procurement list at the national level for medical equipment and testing supplies

________________

Pursuant to the Law on Bidding No. 22/2023/QH15 amended and supplemented by Law No. 57/2024/QH15 and Law No. 90/2025/QH15;

Pursuant to the Government's Decree No. 214/2025/NĐ-CP dated August 4, 2025 detailing certain provisions and implementing measures of the Law on Bidding regarding the selection of contractors;

Pursuant to the Government's Decree No. 42/2025/NĐ-CP dated February 27, 2025 stipulating the functions, tasks, powers, and organizational structure of the Ministry of Health;

At the proposal of the Director of the Medical Infrastructure and Equipment Department;

The Minister of Health hereby issues the centralized procurement list at the national level for medical equipment and testing supplies.

Article 1. Scope of Regulation

This Circular stipulates the centralized procurement list at the national level for medical equipment and testing supplies as provided for in point a, Clause 2, Article 53 of the 2023 Law on Bidding.

Article 2. Principles and Criteria for Building the List

1. Principles: Medical equipment and testing supplies included in the list must be those that need to be procured in large quantities and similar types by one or more agencies, organizations, or units as prescribed in Clause 1, Article 53 of the Law on Bidding.

2. Criteria for Building the List:

The selection of medical equipment and testing supplies in accordance with the principle set forth in Clause 1 of this Article shall be based on meeting the following three criteria simultaneously:

a) Medical equipment and testing supplies with high costs, frequent usage, and significant impact on the payment capacity of the Health Insurance Fund.

b) Results of the pilot centralized bidding for medical supplies during the period 2019-2020.

c) Compatibility with professional needs and feasibility in implementation.

Article 3. Centralized Procurement List at the National Level for Medical Equipment and Testing Supplies

1. Artificial intraocular lenses, including the following types:

a) Soft, single vision, non-spherical, two-hinged, made of non-hydrated acrylic material, yellow color, not pre-installed in an injector.

b) Soft, single vision, non-spherical, two-hinged, made of hydrated acrylic material, yellow color, not pre-installed in an injector.

c) Soft, single vision, non-spherical, two-hinged, made of non-hydrated acrylic material, clear and colorless, not pre-installed in an injector.

d) Soft, single vision, non-spherical, two-hinged, made of hydrated acrylic material, clear and colorless, not pre-installed in an injector.

2. Coronary artery stents, including the following types:

a) Drug-eluting stent coated with Sirolimus polymer, frame made of alloy with stent thickness > 60µm.

b) Drug-eluting stent coated with Everolimus polymer, frame made of alloy with stent thickness > 60µm.

Article 4. Effective Date

1. This Circular takes effect from March 1, 2026.

2. In cases where the referenced documents in this Circular are replaced or amended, they shall be implemented according to the replacement or amendment documents.

Article 5. Implementation Schedule

1. Relevant agencies, organizations, and units are responsible for preparing necessary conditions to implement this Circular in accordance with the law on bidding from the date this Circular takes effect.

2. Centralized procurement at the national level for medical equipment and testing supplies as specified in this Circular will be carried out from January 1, 2027.

Article 6. Implementation Organization

1. The Medical Infrastructure and Equipment Department is responsible for compiling and reporting to the Ministry of Health to amend and supplement the centralized procurement list at the national level for medical equipment and testing supplies in line with practical circumstances.

2. The Planning and Finance Department is responsible for coordinating with relevant units under the Ministry of Finance and the Ministry of Health to guide the implementation of centralized procurement at the national level for medical equipment and testing supplies.

3. Agencies, organizations, and units assigned the task of centralized procurement at the national level for medical equipment and testing supplies are responsible for implementing this Circular in accordance with the law on bidding.

During the implementation process, if there are any difficulties regarding the centralized procurement list for medical equipment and testing supplies, relevant agencies, organizations, and individuals should promptly report to the Ministry of Health (Medical Infrastructure and Equipment Department) for consideration and resolution.

To be received by:
- The Secretariat of the Party Central Committee;
- The Prime Minister, Deputy Prime Ministers;
- Ministries, ministerial-level agencies, and government agencies;
- Provincial People's Councils and People's Committees;
- The Central Party Office and Party Committees;
- The Office of the General Secretary;
- The President's Office;
- The National Assembly's Ethnic Council and Committees;
- The National Assembly's Office;
- The Supreme People's Court;
- The Supreme People's Procuracy;
- State Audit Office;
- Social Policy Bank;
- Vietnam Development Bank;
- Vietnam Fatherland Front Central Committee;
- Central agencies of mass organizations;
- Minister (for reporting);
- Deputy Ministers of the Ministry of Health (for coordination and guidance);
- Departments of Health of provinces and centrally-administered cities;
- Official Gazette; Government Portal;
- Departments, Bureaus, and the Ministry's Office;
- Ministry of Health;
- Ministry of Health Portal;
- File: VT, HTTB, PC.

DEPUTY MINISTER
DEPUTY MINISTER

(Signed)

Do Xuan Tuyen

Original document (PDF)

Open PDF in a new tab ↗